Urinary Tract Infection and Associated Factors among Pregnant Women Receiving Antenatal Care at a Primary Health Care Facility in the Northern Region of Ghana
Table 3
Multidrug resistance profile of isolated bacteria.
Bacteria
N
R0
R1
R2
R3
R4
R5
R6
R7
MDR
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
n
(%)
CoNS
30
4
(13.3)
4
(13.3)
2
(6.7)
5
(16.7)
8
(26.7)
5
(16.7)
2
(6.7)
0
(0.0)
20
(66.7)
Enterococcus Faecalis
25
2
(8.0)
0
(0.0)
0
(0.0)
3
(12.0)
4
(16.0)
4
(16.0)
2
(8.0)
1
(4.0)
14
(56.0)
Staphylococcus aureus
15
0
(0.0)
0
(0.0)
2
(13.3)
5
(33.3)
3
(20.0)
3
(20.0)
2
(13.3)
0
(0.0)
13
(86.7)
Streptococcus sp.
7
0
(0.0)
0
(0.0)
0
(0.0)
2
(28.6)
1
(14.3)
3
(42.9)
0
(0.0)
0
(0.0)
6
(85.7)
Citrobacter sp.
8
1
(12.5)
0
(0.0)
0
(0.0)
2
(25.0)
3
(37.5)
2
(25.0)
0
(0.0)
0
(0.0)
7
(87.5)
Enterobacter sp.
12
0
(0.0)
0
(0.0)
2
(16.7)
1
(8.3)
2
(16.7)
6
(50.0)
1
(8.3)
0
(0.0)
10
(83.3)
Escherichia coli
62
5
(8.1)
12
(19.4)
10
(16.1)
6
(9.7)
8
(12.9)
13
(21.0)
5
(8.1)
3
(4.8)
35
(56.5)
Klebsiella sp.
23
0
(0.0)
2
(8.7)
3
(13.0)
5
(21.7)
6
(26.1)
7
(30.4)
0
(0.0)
0
(0.0)
18
(78.3)
Proteus sp.
28
2
(7.1)
4
(14.3)
2
(7.1)
5
(17.9)
7
(25.0)
5
(17.9)
2
(7.1)
1
(3.6)
20
(71.4)
P. aeruginosa
8
2
(25.0)
0
(0.0)
0
(0.0)
4
(50.0)
2
(25.0)
1
(12.5)
0
(0.0)
0
(0.0)
7
(87.5)
Serratia sp.
5
1
(20.0)
0
(0.0)
2
(40.0)
2
(40.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
2
(40.0)
223
17
(7.6)
23
(10.3)
25
(11.2)
43
(19.3)
48
(21.5)
54
(24.2)
20
(9.0)
12
(5.4)
152
(68.2)
Note. R0, no antibiotic resistance; R1, resistance to one; R2, resistance to two; R3, resistance to three; R4, resistance to four; R5, resistance to five; R6, resistance to six; R7, resistance to seven; MDR, multidrug-resistant.
